Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term hepatocellular-carcinoma. Found 26 abstracts

no pagination
Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, Plastaras J, Bucci MK, Yock TI, Bonilla L, Price R, Harris EE, Konski AA, Stinseymour M. An evidence based review of proton beam therapy: The report of ASTRO's emerging technology committee. Radiotherapy and Oncology. 2012 Apr;103(1):8-11.   PMCID: not NIH funded
Malofeeva EV, Domanitskaya N, Gudima M, Hopper-Borge EA. Modulation of the ATPase and Transport Activities of Broad-Acting Multidrug Resistance Factor ABCC10 (MRP7). Cancer Research. 2012 Dec;72(24):6457-67.   PMCID: PMC 3525726
Zoulim F, Mason WS. Reasons to consider earlier treatment of chronic HBV infections. Gut. 2012 Mar;61(3):333-6.   PMCID: *
McHugh JA, Cullison S, Apuzzio J, Block JM, Cohen C, Leong SL, London WT, McNellis RJ, Neubauer RL, Perrillo R, Squires R, Tarrant D, McMahon BJ. Chronic hepatitis B infection: A workshop consensus statement and algorithm. Journal of Family Practice. 2011 Sep;60(9):E1-8.   PMCID: not NIH funded
Nie H, Evans AA, London WT, Block TM, Ren XD. Ultrasensitive Quantification of Hepatitis B Virus A1762T/G1764A Mutant by a SimpleProbe PCR Using a Wild-Type-Selective PCR Blocker and a Primer-Blocker-Probe Partial-Overlap Approach. Journal of Clinical Microbiology. 2011 Jul;49(7):2440-8.   PMCID: PMC3147845
Nie H, Evans AA, London WT, Block TM, Ren XD, Rman Wf VP. Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysis. Journal of Clinical Virology. 2011 Aug;51(4):230-6.   PMCID: PMC3133867
Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappa B-independent, proteasome-mediated mechanism - art. no. 183. Molecular Cancer. 2010 Jul;9:183.   PMCID: PMC3044330
Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, McMahon BJ, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB. Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B. Pediatrics. 2009 Nov;124(5):E1007-E1013.   PMCID: not NIH funded
Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wustefeld T, Borlak J, Manns MP, Trautwein C. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo. Hepatology . 2006 Jul;44(1):164-73.
Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, Mehta AS. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proceedings of the National Academy of Sciences of the United States of America. 2005 Jan 18;102(3):779-84.
Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma - Prognostic features and natural history. American Journal of Clinical Oncology-Cancer Clinical Trials. 1999 Feb;22(1):22-8.
Pugh JC, Guo JT, Aldrich C, Rall G, Kajino K, Tennant B, England JM, Mason WS. Aberrant expression of a cytokeratin in a subset of hepatocytes during chronic WHV infection. Virology. 1998 Sep 15;249(1):68-79.
Di Q, Summers J, Burch JB, Mason WS. Major differences between WHV and HBV in the regulation of transcription. Virology. 1997 Mar 03;229(1):25-35.
Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrobial Agents and Chemotherapy. 1997 Aug;41(8):1715-20.
Lattanzi JP, Coia LR, Scher RM, Engstrom PF, Hoffman JP, Eisenberg BF, Sigursdson ER, Epstein BE, Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. Gi Cancer. 1997 Jan;2(2):111-7.
Goldstein LJ. MDR1 gene expression in solid tumours. European Journal of Cancer. 1996 Jun;32A(6):1039-50.
Payne RJ, Nowak MA, Blumberg BS. The dynamics of hepatitis B virus infection. Proceedings of the National Academy of Sciences of the United States of America. 1996 Jun 25;93(13):6542-6.
Feitelson MA, Duan LX, Guo JH, Blumberg BS. X-Region Deletion Mutants Associated with Surface Antigen- Positive Hepatitis-B Virus-Infections. Gastroenterology. 1995 Jun;108(6):1810-9.
Feitelson MA, Duan LX, Guo J, Horiike N, McIntyre G, Blumberg BS, Thomas HC, Carman W. Precore and X-Region Mutants in Hepatitis-B Virus-Infections among Renal Dialysis Patients. Journal of Viral Hepatitis. 1995 Jan;2(1):19-31.
Feitelson MA, Duan LX, Guo J, Sun B, Woo J, Steensma K, Horiike N, Blumberg BS. X-Region Deletion Variants of Hepatitis-B Virus in Surface Antigen-Negative Infections and Non-a, Non-B-Hepatitis. Journal of Infectious Diseases. 1995 Sep;172(3):713-22.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term hepatocellular-carcinoma

hepatocellular-carcinoma dna chemotherapy risk gene product(s) liver cancer surface-antigen chronic liver-disease hepatoma-cell lines lung-cancer liver-disease transgenic mice natural-history hepadnavirus infections seroconversion lamivudine tumor viral replication hepatitis e-antigen management virus infection activation infection expression reverse transcription in-vitro drug-resistance glutathione-s-transferase iii-promoters mutations prevention renal- progression randomized trial posttransfusion hepatitis induction nucleotide-binding non-a chicken hepatoma- phase-ii breast-cancer surface-antigen gene clonal expansion hepatitis 8 virus nucleoside analogs antiferritin cell carcinomas human keratin-18 growth-factor-ii hepatitis b virus therapy-oncology-group tumor-necrosis-factor united-states hbeag photon remission colorectal-cancer multidrug-resistance gene pathogenesis chronic hepatitis-b hepatic carcinoma treatment messenger-rna state Mutation fibrolamellar non-b hepatitis cirrhosis qPCR gene amplification metastatic metastases polymerase chain-reaction adriamycin association radiation therapy natural- associations basal core promoter viral load serum radiation-therapy identification protein-7 abcc10 blood-donors c virus glycomics hepatitis-b virus hepatocellular carcinoma hepatitis-virus carriers amplification mortality hepadnavirus insertion culture assay chronic hepatitis B-pediatrics-screening-disease management-liver 2011 en cf-gastroenterology-v141 invitro epithelial-cells genotype-f cell lung-cancer hydrolysis monoclonal-antibodies fulminant- Precore SimpleProbe hepatocytes children therapy carrier state genome core-promoter virus-infection interferon vaccination hbv kidney cells iap mammalian-cells history region localization signal acceleration carriers skull base proteomics cloned viral-dna HBV proteins p-glycoprotein atpase binding-protein Radiation therapy Proton beam therapy-Evidence based guidelines precore mutants zinc reversal agents virus variation increase radiotherapy protein diagnosis hepatoma escherichia-coli fluorouracil antibody stem-cells core antigen e-antigen seroconversion uveal altered glycosylation
Last updated on Wednesday, August 12, 2020